CVE-2026-33213: Redash is a package for data visualization and sharing
CVE-2026-33213 is a medium-severity flaw (CVSS 6.1) affecting redash. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Redash is a package for data visualization and sharing. From 5.0.2 to 26.3.0, the get_next_path() function in Redash's authentication module stripped the scheme and netloc from user-supplied next parameters but did not normalize multiple leading slashes, allowing a crafted login URL such as /login?next=////evil.com to redirect users to an external attacker-controlled site after authentication.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.3% (top 78%) |
| CISA exploited list | No |
| Weakness | CWE-601 |
| Published | 2026-07-15 |
| Last modified | 2026-10-24 |
Last updated 2026-10-24 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-33213?
redash: upgrade to 26.03.1. Exact commands for each OS are on this page.
Is CVE-2026-33213 being exploited?
CVE-2026-33213 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-33213 affect?
CVE-2026-33213 affects redash. Severity is medium (CVSS 6.1). Redash is a package for data visualization and sharing. From 5.0.2 to 26.3.0, the get_next_path() function in Redash's authentication module stripped the scheme and netloc from user-supplied next parameters but did not normalize multiple le
How urgent is CVE-2026-33213?
Priority 27/100. No elevated risk signals yet.